The role of renal prostaglandin E and kallikrein in pathogenesis of essential hypertension.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000097:blood; D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D004039:Diet, Sodium-Restricted; D005260:Female; D005665:Furosemide / Q000494:pharmacology; D006801:Humans; D006973:Hypertension / Q000209:etiology* / Q000652:urine; D007213:Indomethacin / Q000494:pharmacology; D007610:Kallikreins / Q000096:biosynthesis / Q000652:urine*; D007668:Kidney / Q000378:metabolism / Q000502:physiology; D008297:Male; D008875:Middle Aged; D011187:Posture; D011188:Potassium / Q000652:urine; D011458:Prostaglandins E / Q000096:biosynthesis / Q000502:physiology / Q000652:urine*; D012083:Renin / Q000097:blood; D012964:Sodium / Q000652:urine; D013148:Spironolactone / Q000494:pharmacology
D011458:Prostaglandins E; D000804:Angiotensin II; D013148:Spironolactone; D000450:Aldosterone; D005665:Furosemide; D012964:Sodium; D007610:Kallikreins; D012083:Renin; D011188:Potassium; D007213:Indomethacin